Article
Increased DHT levels in androgenic alopecia have been selected for to protect men from prostate cancer.
Medical hypotheses - 1 Apr 2014
Bhargava Shiva
Abstract excerpt
Androgenic alopecia, a condition characterized by increased levels of DHT could have been selected for due to the benefits that prostaglandin D2 (PGD(2)) has on the prostate. A DHT metabolite can increase the transcription of prostaglandin D2 synthase through estrogen receptor beta. The increase...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
